CRISPR Insider™

CRISPR News and Information from Around The World

This Company Wants to Rewrite the Future of Genetic Disease—Without Crispr Gene Editing – WIRED

Posted by btwatson on July 7, 2020 4:25 pm
Tags:
Categories: CRISPR-Google

This Company Wants to Rewrite the Future of Genetic Disease—Without Crispr Gene Editing – WIRED

[unable to retrieve full-text content]

This Company Wants to Rewrite the Future of Genetic Disease—Without Crispr Gene Editing  WIRED
Published at Tue, 07 Jul 2020 18:13:20 +0000

< CRISPR Insider™ home

Crispr News

  • The science behind colorful snakes - study - The Jerusalem Post
    February 4, 2023
  • Vertex (VRTX) to Report Q4 Earnings: What's in the Cards? - Nasdaq
    February 3, 2023
  • 3 No-Brainer Growth Stocks to Buy in 2023 - The Motley Fool
    February 3, 2023
  • Genome-wide CRISPRi screen identifies enhanced autolithotrophic ... - pnas.org
    February 3, 2023
  • Why Editas Medicine's Shares Jumped This Week - Nasdaq
    February 3, 2023
  • CRISPR metabolic screen identifies ATM and KEAP1 as targetable ... - pnas.org
    February 3, 2023
  • The real-life Jurassic Park: Inside plans to bring back dodos, Tasmanian tigers and woolly mammoths - Daily Mail
    February 3, 2023
  • ‘Self-harm and decay are not inevitable': This 45-year-old tech mogul spends $2M per year to get an '18-year-old body' — here are 3 top anti-aging stocks to watch now - Yahoo Finance
    February 3, 2023
  • CRISPR Technology Market Outlook, Strategies, Challenges, Advancements, Geography Trends and Growth, Applicati - openPR
    February 3, 2023
  • Gilead spells out allogeneic cell therapy doubts - Evaluate Pharma
    February 3, 2023
  • A decade on Crispr is already poised to deliver on its promise - Chemistry World
    February 3, 2023
  • CRISPR study questions everything we know about "love hormone" oxytocin - New Atlas
    February 3, 2023
  • Alligator-Catfish Hybrids Are Being Spawned in an Alabama Lab - Outdoor Life
    February 2, 2023
  • Week in Review: IVD firms cope with declining COVID-19 revenues ... - LabPulse
    February 2, 2023
  • 3 CRISPR Stocks to Buy Now Or You'll Be Kicking Yourself Later - InvestorPlace
    February 2, 2023
  • CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
    CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
  • CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
  • The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
    The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
  • The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
  • ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
    ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
  • The Dark Side of CRISPR – Scientific American
    The Dark Side of CRISPR – Scientific American
  • ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
    ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
  • Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
    Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
  • DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
    DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
  • CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
    CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
  • Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
    Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
  • Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
    Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
  • Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
    Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
  • New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
    New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
  • After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
    After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
  • Load more [+]

Copyright 2020 CrisprInsider.com